Eli Lilly, Foghorn enter into pact to develop genetic cancer treatments by Editor | Dec 14, 2021 | Hospitals, LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0 USA – Loxo Oncology, an Eli Lilly and Company R&D group, and Foghorn Therapeutics Inc... Read More